InnovAge (INNV) vs Starling Oncology (STLN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
InnovAge (INNV) has outperformed Starling Oncology (STLN) over the past year, gaining 75.2% versus a gain of 68.3%. Over five years, INNV leads with a +42.2% price change compared with -35.4% for STLN. InnovAge is the larger company by market cap ($1.25 billion vs $655.3 million), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INNV | STLN |
|---|---|---|
| Share price | $9.13 | $6.43 |
| Market cap | $1.25B | $655.32M |
| 1-day change | +1.44% | -2.28% |
| YTD return | +75.92% | +80.62% |
| 1-year return | +75.24% | +68.32% |
| 5-year return | +42.21% | -35.38% |
| Forward P/E | 18.26 | — |
| EPS (TTM) | $-0.02 | $-0.28 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.64 | $7.13 |
| 52-week low | $3.94 | $2.32 |
| Distance from 52-week high | -27.77% | -9.82% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +31.43% | +39.97% |
| Average volume | 441.96K | 1.55M |
| Shares outstanding | 136.45M | 101.92M |
| Employees | 2,500 | 641 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Care Facilities | Medical Care Facilities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About InnovAge
INNV stock →InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors.
Healthcare · Medical Care Facilities · 2,500 employees
About Starling Oncology
STLN stock →Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.
Healthcare · Medical Care Facilities · 641 employees
INNV vs STLN FAQ
Which is bigger, InnovAge or Starling Oncology?
InnovAge (INNV) is larger, with a market capitalization of $1.25B compared with $655.32M for Starling Oncology (STLN).
Which stock has performed better over the past year, INNV or STLN?
INNV returned +75.24% over the past 12 months, compared with +68.32% for STLN (price return, excluding dividends). Past performance does not predict future results.
Are InnovAge and Starling Oncology in the same industry?
Yes. Both are classified in the Medical Care Facilities industry within the Healthcare sector.